Literature DB >> 9482905

The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1.

M Bléry1, H Kubagawa, C C Chen, F Vély, M D Cooper, E Vivier.   

Abstract

An emerging family of cell surface inhibitory receptors is characterized by the presence of intracytoplasmic immunoreceptor tyrosine-based inhibition motifs (ITIM). These ITIM-bearing inhibitory receptors, which are typically paired with activating isoforms, associate with Src homology domain 2-containing phosphatases following ITIM tyrosine phosphorylation. Two categories of phosphatases are recruited by the ITIM-bearing receptors: the protein-tyrosine phosphatases, SHP-1 and SHP-2, and the polyphosphate inositol 5-phosphatase, SHIP. The dynamic equilibrium of B cell activation is partially controlled by two well known ITIM-bearing receptors, CD22 and FcgammaRIIB, a low affinity receptor for IgG. We describe here that a murine ITIM-bearing molecule, PIR-B, can also negatively regulate B cell activation. Tyrosine-phosphorylated ITIMs allow PIR-B to associate with SHP-1 but not with SHIP. Engagement of PIR-B thereby initiates a SHP-1-dependent inhibitory pathway that may play an important role in regulating B lymphocyte activation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9482905      PMCID: PMC19370          DOI: 10.1073/pnas.95.5.2446

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase.

Authors:  C Bottino; M Vitale; L Olcese; S Sivori; L Morelli; R Augugliaro; E Ciccone; L Moretta; A Moretta
Journal:  Eur J Immunol       Date:  1994-10       Impact factor: 5.532

2.  Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation.

Authors:  B A Binstadt; K M Brumbaugh; C J Dick; A M Scharenberg; B L Williams; M Colonna; L L Lanier; J P Kinet; R T Abraham; P J Leibson
Journal:  Immunity       Date:  1996-12       Impact factor: 31.745

Review 3.  The emerging field of receptor-mediated inhibitory signaling: SHP or SHIP?

Authors:  A M Scharenberg; J P Kinet
Journal:  Cell       Date:  1996-12-13       Impact factor: 41.582

4.  Selective in vivo recruitment of the phosphatidylinositol phosphatase SHIP by phosphorylated Fc gammaRIIB during negative regulation of IgE-dependent mouse mast cell activation.

Authors:  D C Fong; O Malbec; M Arock; J C Cambier; W H Fridman; M Daëron
Journal:  Immunol Lett       Date:  1996-12       Impact factor: 3.685

5.  Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB.

Authors:  M Ono; S Bolland; P Tempst; J V Ravetch
Journal:  Nature       Date:  1996-09-19       Impact factor: 49.962

6.  Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways.

Authors:  J Samaridis; M Colonna
Journal:  Eur J Immunol       Date:  1997-03       Impact factor: 5.532

7.  Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases.

Authors:  L Olcese; P Lang; F Vély; A Cambiaggi; D Marguet; M Bléry; K L Hippen; R Biassoni; A Moretta; L Moretta; J C Cambier; E Vivier
Journal:  J Immunol       Date:  1996-06-15       Impact factor: 5.422

8.  Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1.

Authors:  D D'Ambrosio; K L Hippen; S A Minskoff; I Mellman; G Pani; K A Siminovitch; J C Cambier
Journal:  Science       Date:  1995-04-14       Impact factor: 47.728

9.  Differential functions of the two Src homology 2 domains in protein tyrosine phosphatase SH-PTP1.

Authors:  D Pei; J Wang; C T Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

10.  Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/PLC-gamma signaling complex in human natural killer (NK) cells.

Authors:  N M Valiante; J H Phillips; L L Lanier; P Parham
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

View more
  40 in total

1.  mSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2.

Authors:  Z Yu; M Maoui; L Wu; D Banville; S Shen
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

2.  Inhibition of IgE-mediated mast cell activation by the paired Ig-like receptor PIR-B.

Authors:  T Uehara; M Bléry; D W Kang; C C Chen; L H Ho; G L Gartland; F T Liu; E Vivier; M D Cooper; H Kubagawa
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

3.  Paternal monoallelic expression of the paired immunoglobulin-like receptors PIR-A and PIR-B.

Authors:  C C Chen; V Hurez; J S Brockenbrough; H Kubagawa; M D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

Review 4.  Mast cell regulation via paired immunoglobulin-like receptor PIR-B.

Authors:  Ching-Cheng Chen; Dong-Won Kong; Max D Cooper; Hiromi Kubagawa
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

5.  Lyn kinase promotes erythroblast expansion and late-stage development.

Authors:  Vinit G Karur; Clifford A Lowell; Peter Besmer; Valter Agosti; Don M Wojchowski
Journal:  Blood       Date:  2006-05-16       Impact factor: 22.113

Review 6.  The conundrum of inhibitory signaling by ITAM-containing immunoreceptors: potential molecular mechanisms.

Authors:  Paul M Waterman; John C Cambier
Journal:  FEBS Lett       Date:  2010-09-28       Impact factor: 4.124

7.  Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation.

Authors:  Geraldine Ferjoux; Frederic Lopez; Jean-Pierre Esteve; Audrey Ferrand; Eric Vivier; Frederic Vely; Nathalie Saint-Laurent; Lucien Pradayrol; Louis Buscail; Christiane Susini
Journal:  Mol Biol Cell       Date:  2003-07-11       Impact factor: 4.138

8.  Differential but competitive binding of Nogo protein and class i major histocompatibility complex (MHCI) to the PIR-B ectodomain provides an inhibition of cells.

Authors:  Haruka Matsushita; Shota Endo; Eiji Kobayashi; Yuzuru Sakamoto; Keisuke Kobayashi; Kohji Kitaguchi; Kimiko Kuroki; Arvid Söderhäll; Katsumi Maenaka; Akira Nakamura; Stephen M Strittmatter; Toshiyuki Takai
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

9.  Identification of natural killer cell receptor clusters in the platypus genome reveals an expansion of C-type lectin genes.

Authors:  Emily S W Wong; Claire E Sanderson; Janine E Deakin; Camilla M Whittington; Anthony T Papenfuss; Katherine Belov
Journal:  Immunogenetics       Date:  2009-07-14       Impact factor: 2.846

Review 10.  Role of PIR-B in autoimmune glomerulonephritis.

Authors:  Toshiyuki Takai; Akira Nakamura; Shota Endo
Journal:  J Biomed Biotechnol       Date:  2010-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.